Aspire Biopharma Holdings Balance Sheet (2021-2026) | ASBP

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter) 0.62M0.58M0.53M0.50M0.32M0.01M0.05M0.02M0.02M0.00M1.35M1.83M
Cash & Current Investments (Quarter) 0.62M0.58M0.53M0.50M0.32M0.01M0.05M0.02M0.02M0.00M1.35M1.83M
Receivables - Other (Quarter) 0.30M0.03M0.04M
Inventory (Quarter) 0.04M0.25M0.37M
Prepaid Assets (Quarter) 0.64M0.63M0.61M0.60M0.59M0.42M0.25M0.08M0.07M0.04M0.14M0.62M0.78M0.42M0.06M0.89M
Current Assets (Quarter) 0.29M1.26M1.21M1.15M1.10M0.91M0.55M0.25M0.08M0.07M0.34M0.15M1.97M0.99M2.40M1.31M7.12M
Non-Current Assets
Long-Term Investments (Quarter) 294.71M295.13M296.46M299.00M302.20M20.02M19.64M19.90M20.14M6.52M6.67M
Other Non-Current Assets (Quarter) 0.53M0.38M0.23M0.08M
Non-Current Assets (Quarter) 295.24M295.51M296.69M299.08M302.20M20.02M19.64M19.90M20.14M6.52M
Assets (Quarter) 0.29M296.50M296.72M297.84M300.18M303.11M20.56M19.89M19.98M20.20M6.87M0.15M1.97M0.99M2.40M1.31M7.12M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 273.000.02M0.08M0.10M0.18M0.20M0.10M0.10M0.15M0.37M0.58M0.31M1.43M1.35M1.06M1.01M0.86M
Notes Payables (Quarter) 0.24M0.92M1.21M1.33M3.55M0.04M
Payables (Quarter) 0.24M0.02M0.08M0.10M0.18M0.20M0.10M0.10M0.15M0.37M0.58M1.23M2.64M2.68M4.62M1.06M0.86M
Accumulated Expenses (Quarter) 0.32M0.38M0.27M1.01M0.44M
Other Accumulated Expenses (Quarter) 0.12M0.18M0.21M0.24M0.27M0.30M0.11M0.35M0.35M0.35M0.35M0.35M
Short term Debt (Quarter) 0.01M0.22M0.43M4.90M3.62M0.50M0.50M4.74M1.29M0.50M
Current Taxes (Quarter) 0.03M0.06M0.09M0.12M0.15M
Total Current Liabilities (Quarter) 0.29M0.05M0.15M0.19M0.30M0.36M0.28M0.32M0.40M2.63M6.24M1.69M9.87M10.56M13.86M7.59M3.15M
Non-Current Liabilities
Non-Current Debt (Quarter) 0.01M0.22M0.43M0.44M0.47M1.50M
Non-Current Deffered Revenue (Quarter) 5.00M0.75M5.00M0.75M0.75M0.75M0.75M5.00M
Preferred Stock Liabilities (Quarter) 294.69M295.13M296.46M299.00M302.20M20.02M19.64M19.90M20.14M6.52M6.67M
Other Non-Current Liabilities (Quarter) 0.16M0.45M0.45M0.45M0.50M1.88M2.03M0.04M
Total Non-Current Liabilities (Quarter) 11.12M0.32M0.25M2.18M5.79M-0.45M1.19M8.04M8.58M7.65M
Total Liabilities (Quarter) 0.29M10.86M10.96M11.00M11.12M11.17M0.28M0.32M0.40M2.63M6.24M1.69M9.92M10.61M13.87M7.69M3.25M
Shareholder's Equity
Total Debt (Quarter) 0.02M0.43M0.86M5.34M4.08M0.50M0.50M4.74M2.79M0.50M
Common Equity (Quarter) -475.00-9.05M-9.37M-9.62M-9.94M-10.26M0.26M-0.06M-0.49M-0.49M-0.56M-0.77M-1.54M-7.95M-9.62M-11.47M-6.38M3.87M
Liabilities and Shareholders Equity (Quarter) 0.29M296.50M296.72M297.84M300.18M303.11M20.56M19.89M19.98M20.20M6.87M0.15M1.97M0.99M2.40M1.31M7.12M
Retained Earnings (Quarter) 0.02M-9.05M-9.37M-9.62M-9.94M-10.26M-10.55M-10.88M-11.29M-13.99M-14.76M1.24M-18.72M11.08M-22.55M20.88M34.35M
Preferred Shares (Quarter) 32.001.00
Treasury Shares (Quarter) 28.75M28.75M1.80M1.80M1.80M1.80M0.58M0.58M0.58M